Effect of COVID-19 Pandemic on Vaccination Compliance

Status Not yet recruiting

Clinical Trial Summary

1- Evaluate the impact of the COVID-19 pandemic on pediatric vaccinations compliance among children attending to Assiut University Children Hospital ,assess the general health profile of studied children.

Clinical Trial Description

Corona virus disease (COVID-19) is a disease caused by a new corona virus called Severe Acute Respiratory Syndrome Corona virus 2 (SARS-CoV-2). On March 11, the WHO Director-General declared COVID-19 a pandemic1. The first outbreak occurred in Wuhan, China. 2,3 COVID-19 pandemic has severely affected global health services.4 It is important not to overlook the value of some public health preventive interventions which cannot be postponed, such as vaccinations.5 As reported by WHO, the disruption of immunization services, even for brief periods, will result in increased numbers of susceptible individuals, raising the risks of an upsurge in outbreak-prone VPDs.6 The reduction of vaccination coverage could cause an increase in morbidity and mortality among children. Consequently, a greater burden could be placed on health systems. Examples from previous large epidemics (e.g. diphtheria in the former Soviet Union in 1990-1996 and in Venezuela in 2017-2018) show that, when vaccination coverage falls or vaccinations are disrupted, cases of infectious diseases that have disappeared can quickly re-emerge.7-8 Egypt declared a national state of emergency to control COVID-19 pandemic and implemented a stay-at-home order. Such strategies might result in decreased accessibility to routine immunization services, leaving children at risk for vaccine-preventable diseases and their complications.9 Great efforts are needed for rapid catch-up of children not up-to-date with routine vaccines. Parental concerns about potentially exposing their children to COVID-19 during vaccination visits might contribute to incompalince.10 Reminding parents of the vital need to protect their children against serious vaccine-preventable diseases is critical. ;

Study Design

Related Conditions & MeSH terms

Vaccine Refusal

Clinical Trial Details

NCT number	NCT04618796
Study type	Observational
Source	Assiut University
Contact	Gehad Gamal, resident doctor
Phone	01006011751
Email	gehadgamal098@gmail.com
Status	Not yet recruiting
Phase
Start date	December 1, 2021
Completion date	May 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04779138` - Increasing Vaccine Uptake in Underresourced Public Housing Areas	N/A
Completed	`NCT04939506` - COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana	N/A
Completed	`NCT04815837` - An Online Intervention Promoting HPV Vaccination Among Chinese MSM	N/A
Completed	`NCT04930965` - Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate	N/A
Completed	`NCT04568590` - Promoting Altruism to Enhance Vaccine Acceptance	N/A
Withdrawn	`NCT04761692` - Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake	N/A
Completed	`NCT06155877` - Testing The Effectiveness Of Two Interventions To Reduce Vaccine Hesitancy Among Adolescents	N/A
Completed	`NCT05661890` - Seasonal Influenza and Pneumococcal Vaccination in the Elderly
Completed	`NCT05804825` - Testing the Persuasiveness of Pro-inoculation Arguments	N/A
Terminated	`NCT03972813` - Optimizing HPV Vaccine Introduction in Shanghai, China	N/A
Enrolling by invitation	`NCT04801030` - COVID-19 Vaccine Hesitancy Among African Americans	N/A
Recruiting	`NCT05069454` - Study on COVID-19 Vaccine Effectiveness Among Health Workers in Azerbaijan	N/A
Completed	`NCT05236270` - CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19)	N/A
Recruiting	`NCT04805931` - VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans	N/A
Recruiting	`NCT05325138` - Assessing Knowledge, Beliefs and Attitudes Toward HPV Vaccination Among Parents in North West, Cameroon
Recruiting	`NCT05677997` - Evaluating the Impact of Resource Navigators to Support LTC and RH Staff During and Beyond COVID-19	N/A
Completed	`NCT05808413` - Exploring the Effect of Video Interventions on Intentions for Continued COVID-19 Vaccination	N/A
Completed	`NCT04960228` - Exploring Changes in COVID-19 Vaccination Intentions by Prompting Altruistic Motives Using a Video Intervention	N/A
Completed	`NCT05022472` - Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California	Phase 4
Not yet recruiting	`NCT06290206` - PREVENT HPV-Related Cancers	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.